Lidocaine Infusion With ANI Monitoring in Spine Surgery.

Phase 4 Unknown 90 enrolled Kaohsiung Medical University Chung-Ho Memorial Hospital

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the analgesic effect of intraoperative continuous lidocaine infusion (1.5 mg/kg/h (ideal body weight)) in combination of analgesia nociception index and depth of anesthesia monitors guided anesthetics adjustment on enhanced recovery after surgery (ERAS) in patients undergoing elective lumbar spine surgery (≥2 sessions).

Timeline

Start: 2023-04-25
Primary completion: 2025-03-31
Completion: 2025-03-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lidocaine	Other / unclassified	1.5 mg/kg	Intravenous

Indications

No indication recorded.